Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Nov;38(11):1229–1234. doi: 10.1136/jcp.38.11.1229

Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

J C van der Linden, J P Baak, T Postma, J Lindeman, C J Meyer
PMCID: PMC499418  PMID: 4066982

Abstract

Serum carcinoembryonic antigen concentrations (serum CEA) in 80 patients with primary breast cancer were measured preoperatively, one month after operation, and thereafter serially every third month. These data were related to histological and morphometric features of the primary breast carcinoma and the lymph node metastases and to clinical follow up data. Analysis of the serum CEA values showed significant correlations with size of tumour, the presence of lymph node metastases, oestrogen receptor, and occurrence of distant metastases. Furthermore, the results indicated that serial determination of serum CEA in the first two years after operation may be useful in monitoring for the occurrence of distant metastases in patients with metastatic spread to lymph nodes and with large (greater than or equal to 2 cm) primary breast tumours positive for oestrogen receptor. In agreement with other studies, however, it was found that the predictive value of serum CEA concentrations in general is weak and costs may prohibit the implementation of the routine assessment of CEA concentrations.

Full text

PDF
1229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baak J. P., Kurver P. H., De Snoo-Niewlaat A. J., De Graef S., Makkink B., Boon M. E. Prognostic indicators in breast cancer--morphometric methods. Histopathology. 1982 May;6(3):327–339. doi: 10.1111/j.1365-2559.1982.tb02727.x. [DOI] [PubMed] [Google Scholar]
  3. Baak J. P., Persijn J. P. In search for the best qualitative microscopical or morphometrical predictor of oestrogen receptor in breast cancer. Pathol Res Pract. 1984 Mar;178(4):307–314. doi: 10.1016/S0344-0338(84)80019-9. [DOI] [PubMed] [Google Scholar]
  4. Bezwoda W., Derman D., Bothwell T., MacPhil P., Levin J., De Moor N. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer. Cancer. 1981 Oct 1;48(7):1623–1628. doi: 10.1002/1097-0142(19811001)48:7<1623::aid-cncr2820480725>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Black M. M., Barclay T. H., Hankey B. F. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer. 1975 Dec;36(6):2048–2055. doi: 10.1002/cncr.2820360919. [DOI] [PubMed] [Google Scholar]
  6. Chatal J. F., Chupin F., Ricolleau G., Tellier J. L., le Mevel A., Fumoleau P., Godin O., le Mevel B. P. Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasis. Eur J Cancer. 1981 Feb;17(2):233–238. doi: 10.1016/0014-2964(81)90041-4. [DOI] [PubMed] [Google Scholar]
  7. De Jong-Bakker M., Hart A. A., Persijn J. P., Cleton F. J. Prognostic significance of CEA in breast cancer: a statistical study. Eur J Cancer Clin Oncol. 1981 Dec;17(12):1307–1313. doi: 10.1016/0014-2964(81)90013-x. [DOI] [PubMed] [Google Scholar]
  8. Falkson H. C., Falkson G., Portugal M. A., van der Watt J. J., Schoeman H. S. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy. Cancer. 1982 May 1;49(9):1859–1865. doi: 10.1002/1097-0142(19820501)49:9<1859::aid-cncr2820490919>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  9. Falkson H. C., Van Der Watt J. J., Portugal M. A., Pitout M. J., Falkson G. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy. Cancer. 1978 Sep;42(3):1308–1313. doi: 10.1002/1097-0142(197809)42:3<1308::aid-cncr2820420341>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  10. Falkson H. C., van der Watt J. J., Portugal M. A., Schoeman H. S., Falkson G. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. Cancer Treat Rep. 1979 Aug;63(8):1303–1309. [PubMed] [Google Scholar]
  11. Haagensen D. E., Jr, Kister S. J., Panick J., Giannola J., Hansen H. J., Wells S. A., Jr Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma. Cancer. 1978 Sep;42(3 Suppl):1646–1652. doi: 10.1002/1097-0142(197809)42:3+<1646::aid-cncr2820420844>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  12. Haagensen D. E., Jr, Kister S. J., Vandevoorde J. P., Gates J. B., Smart E. K., Hansen H. J., Wells S. A., Jr Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer. 1978 Sep;42(3 Suppl):1512–1519. doi: 10.1002/1097-0142(197809)42:3+<1512::aid-cncr2820420824>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  13. Lee Y. T. Carcinoembryonic antigen as a monitor of recurrent breast cancer. J Surg Oncol. 1982 Jun;20(2):109–114. doi: 10.1002/jso.2930200209. [DOI] [PubMed] [Google Scholar]
  14. Mansour E. G., Hastert M., Park C. H., Koehler K. A., Petrelli M. Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor. Cancer. 1983 Apr 1;51(7):1243–1248. doi: 10.1002/1097-0142(19830401)51:7<1243::aid-cncr2820510712>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  15. Myers R. E., Sutherland D. J., Meakin J. W., Kellen J. A., Malkin D. G., Malkin A. Carcinoembryonic antigen in breast cancer. Cancer. 1978 Sep;42(3 Suppl):1520–1526. doi: 10.1002/1097-0142(197809)42:3+<1520::aid-cncr2820420825>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  16. Neville A. M., Patel S., Capp M., Laurence D. J., Cooper E. H., Turberville C., Coombes R. C. The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. Cancer. 1978 Sep;42(3 Suppl):1448–1451. doi: 10.1002/1097-0142(197809)42:3+<1448::aid-cncr2820420812>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  17. Tormey D. C., Waalkes T. P., Ahmann D., Gehrke C. W., Zumwatt R. W., Snyder J., Hansen H. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides. Cancer. 1975 Apr;35(4):1095–1100. doi: 10.1002/1097-0142(197504)35:4<1095::aid-cncr2820350412>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  18. Tormey D. C., Waalkes T. P., Snyder J. J., Simon R. M. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer. 1977 Jun;39(6):2397–2404. doi: 10.1002/1097-0142(197706)39:6<2397::aid-cncr2820390614>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  19. Wahren B., Lidbrink E., Wallgren A., Eneroth P., Zajicek J. Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma. Cancer. 1978 Oct;42(4):1870–1878. doi: 10.1002/1097-0142(197810)42:4<1870::aid-cncr2820420426>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  20. Wang D. Y., Bulbrook R. A., Hayward J. L., Hendrick J. C., Franchimont P. Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur J Cancer. 1975 Sep;11(9):615–618. doi: 10.1016/0014-2964(75)90094-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES